𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PA.105 AGE AFFECTS ADHERENCE TO PEGINTERFERON-ALPHA AND RIBAVIRIN IN “DIFFICULT-TO-TREAT” PATIENTS WITH CHRONIC HEPATITIS C

✍ Scribed by I. Lenci; S. Francioso; M. Carbone; F. De Leonardis; L. Baiocchi; M. Angelico

Book ID
119632780
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
65 KB
Volume
40
Category
Article
ISSN
1590-8658

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C treatment in “difficult-to-t
Hepatitis C treatment in “difficult-to-treat” psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects
✍ Martin Schaefer; Axel Hinzpeter; Ariane Mohmand; Gesa Janssen; Maurice Pich; Mar 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

We investigated and compared the results of treating the chronic hepatitis C (HCV) infection of different groups of psychiatric-risk patients and controls with pegylated interferon alpha (pe-gIFN-␣) plus ribavirin. Seventy patients were prospectively screened for psychiatric disorders. Seventeen pat

Improved outcomes in patients with hepat
Improved outcomes in patients with hepatitis C with difficult-to-treat characteristics: Randomized study of higher doses of peginterferon α-2a and ribavirin
✍ Michael W. Fried; Donald M. Jensen; Maribel Rodriguez-Torres; Lisa M. Nyberg; Ad 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB 👁 2 views

Treatment response remains suboptimal for many patients with chronic hepatitis C, particularly those with genotype 1 and high levels of viremia. The efficacy of high-dose regimens of peginterferon alfa-2a and ribavirin was compared with conventional dose regimens in patients with features predicting